Skip to main content
. 2020 Feb 24;56(5):1199–1211. doi: 10.3892/ijo.2020.4998

Figure 6.

Figure 6

Survival curves of patients stratified by IRS based on stage or grade. Differences in survival in patients with hepatocellular carcinoma. Patients were stratified according to IRS, and the survival of patients with (A) stage I&II, (B) stage III&IV, (C) grade 1 & 2 and (D) grade 3&4 cancer was compared in the patients from TCGA. (E) Survival of patients from ICGC stratified according IRS. Differences in survival with (E) stage I & II or (F) stage III & IV. Survival was compared using a log-rank test; P<0.05 was considered to indicate a statistically significant difference. IRS, immune risk score; TCGA, The Cancer Genome Atlas; ICGC, International Cancer Gene Consortium; CI, confidence interval.